Log in to save to my catalogue

Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endo...

Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1876794574

Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice

About this item

Full title

Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-03, Vol.12 (3), p.e0173661-e0173661

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Erythropoietin (EPO), clinically used as a hematopoietic drug, has received much attention due to its nonhematopoietic effects. EPO reportedly has beneficial effects on obesity and diabetes mellitus. We investigated whether interscapular brown adipose tissue (iBAT: main part of classical BAT) could play a role in EPO's anti-obesity and anti-diabeti...

Alternative Titles

Full title

Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1876794574

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1876794574

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0173661

How to access this item